Skip to main content
. 2022 Mar 25;13:864133. doi: 10.3389/fimmu.2022.864133

Table 2.

Diagnostic performances of the different biomarkers for MSARD diagnosis compared to both control populations.

MSARD vs. NIND n = 141 MSARD vs. OIND n = 123
AUC (%) 95% CI Optimal threshold AUC (%) 95% CI Optimal threshold
KFLC index 90.0a [84.9; 95.2] 8.4 82.3 [74.6; 90.0] 13.1
KFLC IF 88.7a [83.0; 94.3] 73.1 74.5c [65.2; 83.8] 82.8
CSF CD25 59.6b [50.1; 69.0] 21.5 77.0d [65.6; 88.5] 41.5
CSF IL-6 56.9b [46.7; 67.1] 2.0 87.4e [79.8; 95.0] 4.1
CSF IL-10 62.7b [56.5; 68.8] 1.2 68.0 [56.6; 79.4] 2.4

CSF, cerebrospinal fluid; KFLC, kappa free light chains; MSARD, multiple sclerosis and related disorder; NIND, non-inflammatory neurological disorder; OIND, other inflammatory neurological disorder; AUC, area under the curve.

a

KFLC index and KFLC IF AUC are not statistically different (p = 0.404).

b

AUCs of CSF CD25, IL-6, and IL-10 were all lower than both KFLC biomarkers (p < 0.001 for all 6 comparisons). There was no AUC difference between CSF CD25 and CSF IL-6 (p = 0.717), CSF CD25 and CSF IL-10 (p = 0.523), and CSF IL-6 and CSF IL-10 (p = 0.314).

c

KFLC index and KFLC IF AUC are statistically different (p = 0.008).

d

CSF CD25 AUC is not statistically different than KFLC index AUC (p = 0.358), CSF IL-6 AUC (p = 0.119), or CSF IL-10 AUC (p = 0.149).

e

CSF IL-6 AUC is not statistically different than KFLC index AUC (p = 0.436) and CSF CD25 AUC (p = 0.119) and is higher than CSF IL-10 AUC (p = 0.007).